BlackRock’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.68M | Sell |
483,083
-487,741
| -50% | -$3.72M | ﹤0.01% | 3819 |
|
|
2025
Q1 | $3.16M | Sell |
970,824
-7,899
| -0.8% | -$25.8K | ﹤0.01% | 3786 |
|
|
2024
Q4 | $4.4M | Buy |
978,723
+26,132
| +3% | +$118K | ﹤0.01% | 3727 |
|
|
2024
Q3 | $2.64M | Buy |
952,591
+48,508
| +5% | +$134K | ﹤0.01% | 3866 |
|
|
2024
Q2 | $3.09M | Sell |
904,083
-1,121,528
| -55% | -$3.84M | ﹤0.01% | 3800 |
|
|
2024
Q1 | $11M | Buy |
2,025,611
+1,638,210
| +423% | +$8.88M | ﹤0.01% | 3251 |
|
|
2023
Q4 | $2.1M | Buy |
387,401
+63,993
| +20% | +$347K | ﹤0.01% | 3948 |
|
|
2023
Q3 | $2.85M | Buy |
+323,408
| New | +$2.85M | ﹤0.01% | 3816 |
|